Goldman Sachs names 2 ASX shares to buy right now

Goldman Sachs is tipping these ASX shares as buys…

| More on:
A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're looking for new investment options for next week, then the two ASX shares listed below could be worth considering.

Both are highly rated by analysts at Goldman Sachs and tipped to generate strong returns for investors. Here's what the broker is saying about these ASX shares:

Hipages Group Holdings Ltd (ASX: HPG)

The first ASX share that Goldman Sachs has just recommended investors buy is Hipages.

It is a leading ANZ-based online platform and software as a service (SaaS) provider connecting consumers with trusted tradies.

Goldman Sachs believes the company has a huge long term growth opportunity. It commented:

Longer term, we believe HPG presents a compelling long growth opportunity as it builds out an essential ecosystem of services for tradies.

In addition, the broker feels the Hipages share price is cheap considering its strong growth potential.

Valuation is supportive relative to global marketplace peers. HPG is trading on 13.9x FY23 EV/EBITDA vs. the median of marketplace peers trading on 15.3x. In our view this does not capture the medium term growth potential of the business: we forecast a 29% EBITDA CAGR (FY22-25E) vs. the median of peers at 14%; we also believe HPG can deliver solid operating leverage over the longer term as the business scales.

Goldman has a buy rating and $2.10 price target on the company's shares. This compares favourably to the current Hipages share price of $1.55.

IDP Education Ltd (ASX: IEL)

Another ASX share that the broker is tipping as a buy is IDP Education. It is a leading language testing and student placement provider.

Goldman was very impressed with the company's FY 2022 results and believes it shows that IDP is becoming the dominant force in English-speaking markets. It said:

We believe IEL's FY22 result reflected 1) operational excellence by managing costs whilst preparing capacity for a strong rebound of students into Australia; and 2) material progress towards becoming the dominant student placement provider into English-speaking markets, including leveraging technology to build a growing presence in the US.

As with Hipages, the broker feels that its shares are cheap considering its strong growth prospects.

IEL is trading c.40% below its 5-yr average P/E premium to the ASX200 Industrials with a forecast 37% FY22-25E EPS CAGR, we remain Buy-rated. We have upgraded EPS in FY23/FY24 by 1.7%/0.8% on the back of the stronger FY22 result, continued strong revenue growth and margin expansion. The balance sheet is in a resilient position with c.A$40mn of net cash to facilitate any bolt-on acquisitions or ramp up in organic investment in new offices and technology.

Goldman has retained its buy rating with an improved price target of $36.00. This compares to the latest IDP Education share price of $28.89.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Hipages Group Holdings Ltd. and Idp Education Pty Ltd. The Motley Fool Australia has positions in and has recommended Hipages Group Holdings Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Broker looking at the share price.
Broker Notes

Broker ratings on 6 ASX shares about to join the ASX 200

These 6 companies will enter the ASX 200 in the December quarter rebalance. Should you buy them?

Read more »

A happy elderly woman smiles and cheers as she looks at good investment news on her laptop.
Broker Notes

Macquarie forecasts this $3.4 billon ASX healthcare share is set surge 33%

Macquarie tips material outperformance from this ASX healthcare share in 2026.

Read more »

Man looking at digital holograms of graphs, charts, and data.
Broker Notes

3 reasons this ASX 300 tech stock is forecast to leap 83% in 2026

A leading broker expects some outsized returns from this ASX 300 tech share. Let’s see why.

Read more »

gold share price represented by speeding golden bullet
Broker Notes

Why this surging ASX All Ords gold stock is tipped to rocket another 233%

A leading broker expects outsized gains from this ASX All Ords gold stock. But not without risk.

Read more »

A blockchain investor sits at his desk with a laptop computer open and a phone checking information from a booklet in a home office setting.
Broker Notes

3 buy-rated ASX 300 shares at 52-week lows

They've fallen far over the past 12 months but have buy ratings from the experts.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Broker Notes

Bell Potter names more of the best ASX 200 shares to buy in December

These are best buys according to the broker. Here's what it is saying about them.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Broker Notes

These ASX 200 shares could rise 30% to 40% in 2026

Looking for big returns? Analysts think these shares could beat the market.

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Broker Notes

Analysts name 3 ASX shares to buy this week

Analysts have good things to say about these shares.

Read more »